Infertility treatment for HIV-positive women

Women's Health

Volumn 4, Issue 4, 2008, Pages 369-382

  Semprini, Augusto Enrico ^a   Hollander, Lital Hannah ^a   Vucetich, Alessandra ^a   Gilling Smith, Carole ^b  

^a ESMAN Medical Consulting   (Italy)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

HIV; Horizontal transmission; Infertility; Self insemination; Seropositive women; Vertical transmission

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RECOMBINANT FOLLITROPIN; STAVUDINE; ZIDOVUDINE;

ANEMIA; CESAREAN SECTION; DRUG MEGADOSE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENITAL TRACT INFECTION; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL HYGIENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INSTRUMENT STERILIZATION; INTRACYTOPLASMIC SPERM INJECTION; MEDICAL AUDIT; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MONOTHERAPY; NAUSEA; PARENTHOOD; POSTOPERATIVE COMPLICATION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE LABOR; REVIEW; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIRUS TRANSMISSION; VOMITING; WOMEN'S HEALTH;

ADULT; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; FERTILIZATION IN VITRO; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INSEMINATION, ARTIFICIAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTIVE TECHNIQUES, ASSISTED; WOMEN'S HEALTH;

EID: 48649095851     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.4.369     Document Type: Review

References (81)

1. Clark RA, Dumiestre J: Women and human immunodeficiency virus: unique management issues. Am. J. Med. Sci. 328(1), 17-25 (2004).
2. Karon JM, Fleming PL, Steketee RW, DeCock KM: HIV in the United States at the turn of the century: an epidemic in transition. Am. J. Public Health 91, 1060-1068 (2001).
3. Elford J, Ibrahim F, Bukutu C, Anderson J: Sexual behaviour of people living with HIV in London: implications for HIV transmission. AIDS 21 (Suppl. 1), S63--S70 (2007).
4. Hoggs RS, Yip B, Chan KJ et al.: Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy (comment). JAMA 286, 2568-2577 (2001)
5. Smit C, Geskus R, Walker R et al.: Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 20(5), 741-749 (2006).
6. Cray GF, McIntyre JA: Effect of HIV on women. AIDS Read. 16(7), 365-368 (2006).
7. European Collaborative Study: Mother-to-child transmission or HIV infection in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 40, 458-465 (2005).
8. Coll O, Fiore S, Floridia M et al.: Pregnancy and HIV infection: a European consensus on management. AIDS 16 (Suppl. 2), S1-S18 (2002).
9. Doyal L, Anderson J: My fear is to fall in love again.... How HIV-positive African women survive in London. Soc. Sci. Med. 60, 1729-1739 (2005)
10. Centers for Disease Control and Prevention: Revised guidelines for HIV counselling, testing, and referral. MMWR Recomm. Rep. 50(RR-19). 1-57 (2001).
11. ACOG Committee Opinion 255: HIV: Ethical Guidelines for Obstetricians and Gynecologists. Obstet. Gynecol. 98, 359-362 (2001).
12. Harries J, Cooper D, Myer L, Bracken H, Zweigenthal V, Orner P: policy maker and health care provider perspectives on reproductive decision-making amongst HIV-infected individuals in South Africa. BMC Public Health 7(147), 282 (2007).
13. Sunderam S, Hollander L, Macaluso M et al.: Safe conception for HIV discordant couples through sperm-washing: experience and perceptions of patients in Milan, Italy. Reprod. Health Matters 16(31), 211-219 (2004).
14. Ciambrone D: Women Experiencing HIV/AIDS: Mending Fractured Selves. In: Living With HIV Infection: The Impact of Illness on Everyday Life. Haworth Press, NY, USA, 43-64 (2005).
15. Panozzo L, Battegay M, Friedl A, Vernazza PL: High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner - two challenging issues. Swiss Med. Wkly 133(7-8), 124-147 (2003).
16. Ogilvie GS, Palepu A, Remale VP et al.: Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS 21(Suppl. 1), S83-S88 (2007).
17. Sowell RL, Murdaugh CL, Addy CL, Moneyham L, Tavokoli A: Factors influencing intent to get pregnant in HIV-infected women living in the southern USA. ALDS Care 14(2), 181-191 (2002).
18. Frodsham LCG, Boag F, Barton S, Gilling-Smith C: Human Immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil. Steril. 85(2), 285-289 (2006).
19. Heard I, Sitta R, Lent F; VESPA Study Group: Reproductive choice in men and women living with HIV: evidence for a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA Study). AIDS 21 (Suppl. 1), S77-S82 (2007).
20. Cooper D, Harries J, Myer L, Orner P, Bracken H: 'Life is still going on': reproductive intentions among HIV-positive women and men in South Africa. Soc. Sci. Med. 65, 274-283 (2007).
21. Martinet M, Manigrat Y, Rozenberg S, Becker B, Gerard M, Delvigne A: Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study. Hum. Reprod. 21(5), 1212-1217 (2006).
22. Gills C, Manigrat Y, Konopnicki D, Barlow P, Rozenberg S: Management and outcome of cervical epithelial neoplasia lesion: a study of matched cases according to HIV status. Gynecol. Onrol. 196, 112-118 (2005).
23. Soncini E, Condemi V: Intraepithelial cervical carcinoma and HIV Prevalence, risk factors and prevention strategies, Minerva Ginecol. 55, 51-55 (2003).
24. Coll O, Lopez M, Vidal R et al.: Fertility assessment in non-infertile HIV-infected women and their partners. Reprod. Biomed. Online 14(4), 488-494 (2007).
25. Stephenson IM, Griffoen A: The effect of HIV diagnosis on reproductive experience. Study group for the medical research council collaborative study on women with HIV. AIDS 10, 1683-1687 (1996).
26. Hinz S, McCormack D, van der Spuy ZM: Endocrine function in HIV-infected women. Dynecol. Endocrinol. 16, 33-38 (2002).
27. Loko MA, Toure S, Dakoury-Dogbo N, Gabillard D, Leroy D, Angalert X: Decreasing Incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort study. AIDS 19, 443-445 (2005).
28. Yaro S, Meda N, Desgrées Du Loû A et al.: Impaired fertility in women infected with HIV-1. Implications for sentinel serosurveillance. Rev. Epidemiol. Sante Publique 49(3), 221-228 (2001).
29. Hunter SC, Isingo R, Boerma JT, Urasa M, Mwaluko GM, Zaba B: The Association between HIV and fertility in a cohort study in rural Tanzania. J. Biosoc. Sci. 35(2), 189-199 (2003).
30. Harlow SD, Schuman F, Cohen M et al.: Effect of HIV infection on menstrual cycle length. J. Acquir Immune Defic. Syndr. 24(1), 68-75 (2000).
31. Clark R, Mulligan K, Stamenovic E et al.: Frequency of anovulation and early menopause among women enrolled in selected AIDS Clinical Trials Group studies. J. Infect. Dis. 184, 1325-1327 (2001).
32. Chirgwin K, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H: Menstrual function in HIV infected women without AIDS. J. Acquir immune Defic. Syndr Hum. Retrovirol. 12, 489-494 (1996).
33. Galling-Smith C, Nicopoullos J, Semprini A, Frodsham L: HIV and reproductive care - a review of current practice. BJOG 113, 1-10 (2006).
34. Hull MG, Glazener CM, Kelly NJ et al.: Population study of causes, treatment and outcome of infertility. Br. Med. J. 291, 1693-1697 (1985).
35. Sobel JD: Gynecologic infections in human immunodeficiency virus-infected women. Clin. Infect. Dis. 31, 1225-1233 (2000).
36. Martin HL Jr, Richardson BA, Nyange PM et al.: Vaginal lactobacilli, microbial flora and risk of human immunodeficiency virus-type-1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1363-1368 (1999)
37. Bukusi EA, Cohen CR, Stevens CE et al.: Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am. J. Obstret. Gynecol. 181, 1374-1381 (1999).
38. Irwin KL, Moorman AC, O'Sullivan MJ et al.: Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet. Gynecol. 95, 525-533 (2000).
39. Cohen C, Sinei R, Reilly M et al..: Effect of human immunodefieciency virus type I infection upon acute salpingitis: a laparoscopic study. J. Infect. Dis. 178, 1352-1358 (1998).
40. Mugo NR, Kiehlbauch JA, Nguti R et al.: Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet. Gynecol. (4). 807-812 (2006).
41. Thornton AC, Romanelli F, Collins JD: Reproduction decision making for couples affected by HIV: a review of the literature. Top. HIV Med. 12(2), 61-67 (2004).
42. Gilling-Smith C, Almeida P: HIV, hepatitis B and hepatitis C and infertility: reducing risk.. Educational Bulletin sponsored by the Practice & Policy Committee of the BFS. Hum. Fertil. 6, 106-112 (2003).
43. Barreiro P, del Romero J, Leal M et al.: Spanish HIV-Discordani Study Group: Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 43(3), 324-326 (2006).
44. Gray RH, Wawer MJ, Brookmeyer R et al.; Rakai Project Team: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357(9263), 1149-1153 (2001).
45. Bujan L, Daudin M, Matsuda T et al.: Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 18(5), 757-766 (2004).
46. García-Bujalance S, Ruiz G, De Guevara CL et al.: Quantitation of human inimunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood. Eur. J. Clin. Microbiol. Infect. Dis. 23(2). 111-115 (2004).
47. Grahama SM, ? SE, Peshuf NM et al.: Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding, AIDS 21, 501-507 (2007).
48. Ohl J, Partisani M, Wittemere C, Lang JM, Viville S. Favre R: Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques. Hum. Reprod. 20, 3136-3140 (2005).
49. Coll O, Vernaeve V, Mataro D et al.: Associated factors to the low reproductive outcome in infertile HIV infected women. Hum. Reprod. 20(51). (Abstract 0-022) (2005).
50. Coll O, Suy A, Figueras F et al.: Decreased pregnancy rate after in vitro fertilization in HIV-infected women receiving HAART. AIDS 20, 121-123 (2006).
51. Terriou P, Anquier P, Chabert-Orsini V et al.: Outcome of ICSI in HIV-1-infected women. Hum. Reprod. 20(10), 2838-2843 (2005).
52. Englert Y, van Henternrijck M, Bostan A et al.: HIV seropositive women expressed reduced fertility in ART. Presented at: XIX World Congress on Fertility & Sterility Durban, South Africa, 29 April-03 May, (2007) (Abstarct FC2803).
53. Baccetti B, Benedetto A, Collodel G, di Caro A, Garbuglia AR, Piomboni P: The debate on the presence of HIV-1 in human gametes. J. Reprod. Immumol. 41, 41-67 (1999).
54. Saada M, Le Chenadec J, Berrei A et al.: Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGESTand SEROCO Study Groups. AIDS 14, 2355-2360 (2000).
55. Martin F, Navaratne L, Khan W et al.: Pregnant women with HIV infection can expect healthy survival. Three-year follow- up. J. Acquir. Immune Defic. Syndr. 43(2), 186-192 (2006).
56. Suy A, Martinez E, Coll O et al.: Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 20, 59-66 (2002).
57. Martí C, Peña JM, Bates I et al.: Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003, Acta Obstet. Gynecol. Scand. 86(4), 409-415 (2007).
58. European Collaborative Study; Swiss Mother and Child HIV Cohort Study: Combination antiretroviral therapy and duration of pregnancy. AIDS 14(18), 2913-2920 (2000).
59. BHIVA Guidelines Writing Committee: Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med.
60. Bertrand E: Presence of HIV-1 in follicular, fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted reproduction technology. AIDS 18, 823-825 (2004).
61. Frodsham LCG, Cox AD, Aimeida PA, Rozis G, Gilling-Smith C: Assisted conception in HIV positive women: risk of mother to embryo viral transmission. Reproduction (Abstract series 30) 0-15 (2004).
62. Brocklehurst P, French R: The association between HIV infection and perinatal outcome; a systematic review of the literature and meta-analysis. Br. J. Obstet. Gynaecol. 105, 836-48 (1998).
63. Rotchford K, Sturm AW, Wilkinson D: Effect of co-infection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systemic review and data synthesis. Sex. Transm. Dis. 27, 243-248 (2000).
64. European Collaborative Study: Mother to child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 40, 458-465 (2005).
65. Sullivan JL: Prevention of mother-to-child transmission of HIV - what next? J. Acquir. Immune Defic. Syndr. 34 (Suppl. 1). S67-S72 (2003).
66. Thorne C, Newell ML: Prevention of mother-to-child transmission of HIV infection. Curr. Opin. Infect. Dis. 17, 247-252 (2004).
67. Minkoff H: Human immunodeficiency virus infection in pregnancy. Obstet. Gynecol. 161, 797-810 (2003)
68. European Parliament and the Council of the European Union: Directive 2004/23EC of the European Parliament and of the. Council of 31 March 2004. Official Journal of the European Union L102, 48-58 (2004)
69. Quint W, Fetter W, Van Os H, Heijtink R: Absence of hepatitis B virus (HBV) in children born after exposure of their mothers to HBV during in vitro fertilization. J. Clin. Microbiol. 32, 1099-1100 (1994).
70. Lesourd F, Izopet J, Mervan C et al.: Transmission of hepatitis C virus during the ancillary procedures for assisted conception. Hum. Reprod. 18, 10-44 (2000).
71. Gilling-Smith C, Emillani S, Almeida P, Liesnard C, Englen Y: Laboratory safety during assisted reproduction in patients with blood-borne viruses. Hum. Reprod. 20, 1433-438 (2005).
72. Clarke GN: Sperm cryopreservation: is there a signifficant risk of cross-contamination? Hum. Reprod. 14, 2941-2943 (1999).
73. Centers for disease control and prevention: Current trends recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/ lymphoadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb. Mortal. Wkly Rep. 34, 721-726 (1985).
74. Kass NE: Policy, ethics and reproductive choice: pregnancy and child-bearing among HIV-infected women. Acta Paediatr: Suppl. 400, 95-98 (1994)
75. Al-Khan A, Colon J, Paita V, Bardeguez A: Assisted reproductive technologies for men and women infected with human immuno deficiency virus type 1. Clin. Infect. Dis. 36, 195-200 (2003).
76. FIGO committee for the ethical aspects of human reproduction and women's health: HIV and fertility treatment. Int. J. Gynaecol. Obstet. 93, 187-188 (2006).
77. Shenfield F, Pennings G, Cohen J, Devroey P, Tarlatzis B, Sureau C: The ESHRE ETHICS and LAW Task Force: Taskforce 8: ethics of medically assisted fertility treatment for HVI positive men and women. Hum. Repiod. 19(11). 2454-2456 (2004).
78. Gining-Smith C: Risking parenthood? Serious viral illness, parenting and welfare of the child. In: Contemporary Ethical Dilemmas in Assisted Reproducaon. Shenfield F, Sureau C (Eds). Informa Healthcare, UK, 5, 57-69 (2006).
79. Frodsham LCG, Smith JR, Gilling Smith C: Assessment of welfare of the child in HIV positive couples. Hum. Reprod. 16(10), 2420-2423 (2004).
80. Bujan L, Hollander L, Coudert M et al.; for the CREAThE network: Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21, 1909-1914 (2007).
81. Pasquier C, Anderson D, Andreutti-Zaugg C et al.: The CREAThE Network: Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation. J. Med. Virol. 78, 877-882 (2006).